Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 2
1993 2
1994 1
1995 5
1996 1
1998 4
1999 3
2000 5
2001 4
2002 2
2003 3
2004 3
2005 4
2006 4
2007 4
2008 4
2009 3
2010 5
2011 8
2012 9
2013 10
2014 6
2015 7
2016 9
2017 12
2018 14
2019 24
2020 15
2021 15
2022 15
2023 13
2024 17
2025 19
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Reviewing the therapeutic role of budesonide in Crohn's disease.
López-Sanromán A, Clofent J, Garcia-Planella E, Menchén L, Nos P, Rodríguez-Lago I, Domènech E. López-Sanromán A, et al. Among authors: nos p. Gastroenterol Hepatol. 2018 Aug-Sep;41(7):458-471. doi: 10.1016/j.gastrohep.2018.05.013. Epub 2018 Jul 12. Gastroenterol Hepatol. 2018. PMID: 30007787 Free article. Review. English, Spanish.
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial.
D'Haens G, Taxonera C, Lopez-Sanroman A, Nos P, Danese S, Armuzzi A, Roblin X, Peyrin-Biroulet L, West R, Mares WGN, Duijvestein M, Gecse KB, Feagan BG, Zou G, Hulshoff MS, Mookhoek A, Oldenburg L, Clasquin E, Bouhnik Y, Laharie D. D'Haens G, et al. Among authors: nos p. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):26-33. doi: 10.1016/S2468-1253(24)00317-0. Epub 2024 Nov 18. Lancet Gastroenterol Hepatol. 2025. PMID: 39571587 Clinical Trial.
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658].
Barreiro-de Acosta M, Marín-Jimenez I, Rodríguez-Lago I, Guarner F, Espín E, Ferrer Bradley I, Gutiérrez A, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: nos p. Gastroenterol Hepatol. 2021 Apr;44(4):320. doi: 10.1016/j.gastrohep.2021.02.001. Epub 2021 Feb 25. Gastroenterol Hepatol. 2021. PMID: 33642094 Free article. English, Spanish. No abstract available.
Medicina de precisión en la enfermedad inflamatoria intestinal.
Mínguez A, Nos P. Mínguez A, et al. Among authors: nos p. Acta Gastroenterol Latinoam. 2022 Sep 29;52(3):334-343. doi: 10.52787/agl.v52i3.245. eCollection 2022 Jul-Sep. Acta Gastroenterol Latinoam. 2022. PMID: 41341374 Free PMC article. Review. Spanish. No abstract available.
Relevance of Clinical Cases.
Balaguer F, Carlota Londoño M, Nos P, Jiménez Moreno MA, Téllez L, Sáez González E. Balaguer F, et al. Among authors: nos p. Gastroenterol Hepatol. 2022 Apr;45 Suppl 1:1. doi: 10.1016/j.gastrohep.2022.02.001. Epub 2022 Feb 8. Gastroenterol Hepatol. 2022. PMID: 35149151 English, Spanish. No abstract available.
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M; EXIT Study group of GETECCU. Gisbert JP, et al. Among authors: nos p. Gut. 2025 Feb 6;74(3):387-396. doi: 10.1136/gutjnl-2024-333385. Gut. 2025. PMID: 39794921 Free PMC article. Clinical Trial.
[Lansoprazol].
Ponce J, Nos P. Ponce J, et al. Among authors: nos p. Gastroenterol Hepatol. 1995 Feb;18(2):101-9. Gastroenterol Hepatol. 1995. PMID: 7621274 Review. Spanish. No abstract available.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Personalised therapy in inflammatory bowel disease.
Calderón P, Núñez P, Nos P, Quera R. Calderón P, et al. Among authors: nos p. Gastroenterol Hepatol. 2024 Aug-Sep;47(7):763-770. doi: 10.1016/j.gastrohep.2023.12.006. Epub 2023 Dec 13. Gastroenterol Hepatol. 2024. PMID: 38101615 Review. English, Spanish.
220 results